Sarah Albertson, BS
Scientist I
Roy Amariglio, PhD, MBA
Principal, OrbiMed, Board Observer
Ruth Berry, PhD
Director, Analytical Development Strategy
Jane Buckner, MD
President, Benaroya Research Institute and Scientific Co-founder
Alaina Burgess, BS
Associate Scientist I
Heidi Chandler, BS
Senior Director, Program Management
Tiffany Chen, PhD
VP, Discovery
Erez Chimovitz, MBA
Partner, OrbiMed, Chairman of the Board
Brian Christin, BS
Senior Director, CMC Strategy Lead
Adam Cotton, PhD, MBA
Associate, Novartis Venture Fund (NVF), Board Observer
Tom Crevier, PhD
Senior Director, Automation, Informatics, and IT
Tristan de Jesús, PhD
Scientist I
Alberto del Rio Espinola, PhD
Director, Translational Sciences
Victoria DeVault, PhD
Associate Director, Technology
Aaron Deykin, MD
CMO, Head of R&D, Upstream Bio, Board Director
Abby Doherty, BS
Associate Scientist II
Emily Doll, BS
Director and Controller
Jaii Fredregill, BA
Senior Executive Assistant
Dalia Gaddis, PhD
Principal Scientist
Irena Gettinger, BS
Project Manager
Carl Gordon, PhD, CFA
Managing Partner & Head of Global Private Equity, OrbiMed, Director
Maggie Gose, BA
Principal Development Associate Scientist
Gidi Gross, PhD
Professor & PI, MIGAL and Scientific Co-Founder
Tim Guo, PhD
Senior Scientist
Kevin Hawkins, BA
Development Scientist II
Hatem Heikal, MBA
VP, Finance
Maegan Hoover, MS
Scientist II
Scott Hussell, BA
Senior Scientist, Analytical Development
Adan Jaramillo, BA
Senior Director, Quality
Amy Jennings, PhD
Principal, RegPath Consulting
Priya Saikumar Lakshmi, PhD
Scientist II
Ashley Landuyt, PhD
Scientist II
Jennifer Mellen, BS
Scientist I
Christopher L. Moore, PhD
Director, Discovery
Mirna Mujacic, PhD
VP, Process and Analytical Development
Conor O’Brien, PhD
Senior Engineer
Brian Oliver, PhD
Principal Development Scientist
Chandra Patel, PhD
Co-founder and Sr. Vice President, Research and Development Operations
Stanford Peng, MD, PhD
President, R&D, Alpine Immune Sciences
Alexa Perdikis, BS
Associate Director, Talent Acquisition & Employee Experience
Jonathan Pritz, PhD
Analyst, RA Capital, Board Observer
Margaret Readio, BS
Director, Head of Technical Development Operations
Nicole Reid, BS
Associate Scientist II, Discovery
Marko Repic, PhD
Director, Pharmacology/Toxicology
David Rawlings, MD
Director, Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Scientific Co-founder and Senior Scientific Advisor
Pramod Rompikuntal, PhD
Principal Scientist
Martina Sassone-Corsi, MS
Senior Scientist
Andy Scharenberg, MD
Scientific Co-founder, SAB Chair, CEO, Umoja Biopharma
Poonam Sharma, PhD
Senior Engineer
Nandita Shangari, PhD
Managing Director RA Capital, Board Director
Michal Silverberg, MBA, MS
Managing Director, Novartis Venture Fund, Board Director
Nishat Shaikh, JD
VP, Intellectual Property & Contracts
Andrew Stuart, BS
Principal Development Associate Scientist
Andy Tran
Biotech Investor, Matrix Capital Management, Board Director
David Tucker, PhD
Principal Scientist
Gene Uenishi, PhD
Associate Director, Discovery
Andy Walker, PhD
President and CEO
Lindsay Webb, PhD
Principal Scientist
Hadas Weinstein-Marom, PhD
Senior Scientist & Lecturer, MIGAL, Scientific Co-Founder
John Wesner, MS
Director, Process Development
Tom Wickham, PhD
Chief Scientific Officer
Jennifer Yam, MS
Scientist I
Rachel Yost, BS
Associate Director, MSAT
Payam Zarin, PhD
Associate Director and Research Lead
Nathan Zammit
Senior Scientist